Pediatrix Medical Group, Inc. (NYSE:MD) Shares Purchased by Barclays PLC

Barclays PLC lifted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 302.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 142,087 shares of the company's stock after acquiring an additional 106,817 shares during the quarter. Barclays PLC owned 0.17% of Pediatrix Medical Group worth $1,646,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Rubric Capital Management LP grew its position in Pediatrix Medical Group by 1.5% during the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock worth $95,907,000 after purchasing an additional 125,000 shares during the period. State Street Corp boosted its stake in shares of Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company's stock worth $41,038,000 after buying an additional 50,597 shares during the last quarter. Geode Capital Management LLC grew its holdings in Pediatrix Medical Group by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company's stock worth $22,452,000 after acquiring an additional 45,155 shares during the period. Dana Investment Advisors Inc. raised its position in Pediatrix Medical Group by 80.3% during the second quarter. Dana Investment Advisors Inc. now owns 1,023,136 shares of the company's stock valued at $7,725,000 after acquiring an additional 455,785 shares in the last quarter. Finally, Weiss Asset Management LP lifted its holdings in Pediatrix Medical Group by 50.5% in the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock valued at $10,580,000 after acquiring an additional 306,143 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Trading Down 2.1 %

Shares of MD traded down $0.27 during mid-day trading on Friday, reaching $12.46. The stock had a trading volume of 396,100 shares, compared to its average volume of 427,728. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. The business's fifty day moving average is $14.30 and its 200 day moving average is $11.62. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $16.41. The firm has a market cap of $1.07 billion, a price-to-earnings ratio of -4.07, a P/E/G ratio of 2.00 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. The business had revenue of $511.20 million during the quarter, compared to analysts' expectations of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The business's revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.29 EPS. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MD has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Thursday. Mizuho increased their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Tuesday, November 19th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a "neutral" rating in a research note on Tuesday, November 5th. Finally, Jefferies Financial Group boosted their price target on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a "buy" rating in a research report on Tuesday, November 5th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $16.25.

Insider Buying and Selling at Pediatrix Medical Group

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of the business's stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total value of $423,660.00. Following the sale, the director now owns 138,683 shares of the company's stock, valued at $2,128,784.05. The trade was a 16.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Mary Ann E. Moore sold 8,108 shares of the company's stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the transaction, the executive vice president now owns 135,810 shares in the company, valued at $2,172,960. This trade represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.